C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y

Diabetologia

Volumn 39, Issue 2, 1996, Pages 199-205

  Ohtomo, Y ^a   Aperia, A ^a   Sahlgren, B ^a   Johansson, B L ^b   Wahren, J ^b  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN; BUCLADESINE; C PEPTIDE; CALPHOSTIN C; INSULIN; NEUROPEPTIDE Y; PERTUSSIS TOXIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; HYPOTHESIS; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING SITES; CALCIUM; CELLS, CULTURED; DRUG SYNERGISM; KIDNEY TUBULES, PROXIMAL; KINETICS; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NEUROPEPTIDE Y; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; TACROLIMUS; VIRULENCE FACTORS, BORDETELLA;

EID: 0030031555     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00403963     Document Type: Article

References (47)

1. Steiner DF, Oyer PE (1967) The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57: 473-480
2. Steiner DF, Clark JL, Nolan C et al. (1969) Proinsulin and the biosynthesis of insulin. Rec Prog Horm Res 25: 207-282
3. Rubenstein AH, Clark JL, Melani F, Steiner DF (1969) Secretion of proinsulin C-peptide by pancreatic β cells and its circulation in blood. Nature 224: 697-699
4. Steiner DF, Kemmler W, Tager HS, Peterson JD (1974) Proteolytic processing in the biosynthesis of insulin and other proteins. Fed Proc 33: 2105-2115
5. Johansson B-L, Sjöberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121-128
6. Johansson B-L, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1151-1158
7. Johansson B-L, Kernell A, Sjöberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77: 976-981
8. + pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat. Diabetes 36: 842-848
9. +-ATPase activity and its α-II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting and refeeding. Metabolism 41: 56-63
10. +-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 265:F96-F101
11. Féraille E, Marsy S, Cheval L et al. (1992) Sites of antinatriuretic action of insulin along rat nephron. Am J Physiol 263:F175-F179
12. +-ATPaSe activity. Kidney Int 45: 1606-1613
13. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J 8: 436-439
14. Doucet A, Katz AI, Morel F (1979) Determination of Na-K-ATPase activity in single segments of the mammalian nephron. Am J Physiol 237:F105-F113
15. Jakobsson B, Larsson SH, Wieslander Å, Aperia A (1990) Amino acid stimulation of Na,K-ATPase activity in rat proximal tubule after high-protein diet. Acta Physiol Scand 139: 9-13
16. Takaichi K, Kurokawa K (1988) Inhibitory guanosine triphosphate-binding protein-mediated regulation of vasopressin action in isolated single medullary tubules of mouse kidney. J Clin Invest 82: 1437-1444
17. Bruns RF, Miller FD, Merriman RL et al. (1991) Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 176: 288-293
18. +-ATPase α 3 isoenzyme in rat pineal glands. Proc Natl Acad Sci USA 87: 1178-1182
19. Larsson S, Aperia A, Lechene C (1986) Studies on the final differentiation of rat renal proximal tubular cells in culture. Am J Physiol 251:C455-C464
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3444-3450
21. Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target for cyclophilincyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815
22. Kobayashi E, Nakano H, Moimoto M, Tamaoki T (1989) Calphostin C (UCN-1028C) a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553
23. Williams G, Gill JS, Lee YC, Cardoso HM, Okpere BE, Bloom SR (1989) Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes 38: 321-327
24. White JD, Olchovsky D, Kershaw M, Berelowit M (1990) Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126: 765-772
25. Akpan JO, Weide LG, Gingerich RL (1993) A specific and sensitive radioimmunoassay for rat C-peptide. Int J Pancreatol 13: 87-95
26. Flatt PR, Swanston-Flatt SK, Hampton SM, Bailey CJ, Marks V (1986) Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep 6: 193-199
27. 86Rb + uptake in rat adipocytes. J Biol Chem 255: 10938-10945
28. +)-ATPase transport activity in isolated rat hepatocytes. J Biol Chem 256: 7449-7453
29. + pump. Biochim Biophys Acta 736: 119-124
30. Gelehrter TD, Shreve PD, Dilworth VM (1984) Insulin regulation of Na/K pump activity in rat hepatoma cells. Diabetes 33: 428-434
31. +)-ATPase. J Biol Chem 260: 10075-10080
32. + and glucose transport in soleus muscle. Am J Physiol 252:E492-E499
33. Birnbaumer L, Abramowitz J, Brown AM (1990) Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031: 163-224
34. +-ATPase activity by dopamine and α-adrenergic agonist. Proc Natl Acad Sci USA 90: 21-24
35. Lundberg JM, Rudehill A, Sollevi A, Theodorsson-Norheim E, Hamberger B (1986) Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 63: 96-100
36. Wahlestedt C, Edvinsson L, Ekblad E, Håkanson R (1985) Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234: 735-741
37. Wahlestedt CR, Håkanson R, Vaz CA, Zukowska-Grojec Z (1990) Norepinephrine and neuropeptide Y: vasocon-strictor cooperation in vivo and in vitro. Am J Physiol 258:R736-R742
38. Aubert JF, Waeber B, Rossier B, Geering K, Nussberger J, Brunner HR (1988) Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents. J Pharmacol Exp Ther 246: 1088-1092
39. +-adenosine triphosphatase in streptozotocin-diabetic rats. J Pharmacol Exp Ther 229: 664-670
40. +-ATPase activity. Pflügers Arch 401: 97-100
41. Wald H, Scherzer P, Popovtzer MM (1986) Enhanced renal tubular ouabain-sensitive ATPase in streptozotocin diabetes mellitus. Am J Physiol 251:F164-F170
42. Khadouri C, Barlet-Bas C, Doucet A (1987) Mechanism of increased tubular Na-K-ATPase during streptozotocin-induced diabetes. Pflügers Arch 409: 296-301
43. Körner A, Eklöf A-C, Celsi G, Aperia A (1994) Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633
44. Greene D, Lattimer AA, Sima AAF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599-606
45. + ATPase activity in acute and chronic diabetes and with aldose reductase inhibition. Diabetes 37: 558-562
46. Greene DA, Sima AAF, Pfeifer MA, Albers JW (1990) Diabetic neuropathy. Annu Rev Med 41: 303-317
47. Johansson B-L, Borg C, Fernqvist-Forbes E, Odengren T, Remal S, Wahren J (1994) Human biosynthetic C-peptide improves autonomic nerve function in patients with type 1 diabetes. Eur J Endocrinol 130[Suppl 1]:25 (Abstract)